TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ProboNova Medical Innovations AB
Closing information (x1000 NOK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
20
|
46
|
26 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-89
|
-9
|
-2 |
| EBITDA |
-90
|
-9
|
-2 |
| Total assets |
74
|
44
|
89 |
| Current assets |
74
|
44
|
89 |
| Current liabilities |
23
|
0
|
40 |
| Equity capital |
51
|
44
|
49 |
| - share capital |
51
|
47
|
49 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
68.9%
|
100%
|
55.1% |
| Turnover per employee |
20
|
46
|
26 |
| Profit as a percentage of turnover |
-445.0%
|
-19.6%
|
-7.7% |
| Return on assets (ROA) |
-120.3%
|
-20.5%
|
-2.2% |
| Current ratio | 321.7% | 222.5% | |
| Return on equity (ROE) |
-174.5%
|
-20.5%
|
-4.1% |
| Change turnover |
-29
|
21
|
-6 |
| Change turnover % |
-59%
|
81%
|
-18% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.